The two surveys, for veterinary surgeons and veterinary nurses respectively, ask the professions a wide range of both quantitative and qualitative questions, covering everything from what they do in a typical working day, to career aspirations, to levels of mental and physical wellbeing.
The surveys are confidential and anonymous.
Lizzie Lockett, RCVS CEO, said: “Our Surveys of the Professions are not just a useful and interesting snapshot of the veterinary professions at a particular moment in time, but are really consequential in terms of what we do with the results.
"For example, information from the previous surveys were used to inform our current Strategic Plan, including our mission to be a compassionate regulator, ongoing support for the Mind Matters Initiative, and a focus on workforce-related issues.
"In a similar spirit, this year’s results will inform the forthcoming RCVS Strategic Plan.
“Of course, the quality of the results of the surveys really depends on hearing from as many of you as possible – so we would like veterinary professionals from all parts of the UK as well as our overseas members, from all backgrounds, of all ages and working on all different disciplines to feed into all areas of the surveys and help us with our research.
"Please don’t miss out on having your say, and a huge thank you for taking the time to support this important work.”
The deadline for completing the survey is on or before Friday 16 February 2024.
Dr Briggs faced four charges and admitted to her conduct in the first three at the outset.
They related to three official Animal and Plant Health Agency (APHA) clinical investigation report forms she submitted following three official avian flu surveillance visits she'd undertaken as an Official Veterinarian (OV).
The three surveillance visits all took place during an outbreak of avian influenza in North Yorkshire and were on behalf of the APHA.
Dr Briggs admitted that she'd certified on each of the three forms that she had inspected specific poultry, that she had seen no clinical signs of avian influenza in the poultry and that in her opinion avian influenza did not exist and had not existed in the previous 56 days.
Dr Briggs also admitted that that she had subsequently submitted the three forms to the APHA.
The fourth charge alleged Dr Briggs conduct in certifying the three forms had been dishonest and that her actions risked undermining procedures, regulations and rules designed to protect animal welfare and public health.
Dr Briggs denied that she had been dishonest in any of her actions but admitted that her conduct had risked undermining procedures designed to protect animal welfare and public health.
Dr Briggs explained that in two cases she had relied on information given to her by the keepers of the poultry and in the remaining case it was possible that she had not visited the correct location of the poultry, had posted a letter through the wrong door and had then accidentally submitted a pre-populated inspection form to APHA.
Having heard evidence from the relevant poultry keepers, fellow Official Veterinarians, officials from the APHA and Dr Briggs herself, the Committee gave its determinations on dishonesty.
In relation to the first two charges, which concerned the visits that did take place, the Committee found Dr Briggs had been dishonest both in submitting the inspection forms to the APHA and also in certifying that she had seen no clinical signs or history of avian influenza in both cases.
The Committee concluded that an ordinary decent person would regard the submission of a signed form which contained false information as dishonest.
It also concluded that Dr Briggs had deliberately signed an official form which contained information which she knew to be untrue.
However, the Committee found that Dr Briggs was not dishonest in asserting on these forms that she was of the opinion that disease did not exist based upon the information provided to her by the poultry keepers.
In relation to the third charge, where Dr Briggs did not visit the property concerned, the Committee did not find it proven that she had been dishonest, having heard her evidence that, in this case, she had accidentally submitted a pre-populated inspection form.
The Committee next considered whether the admitted and proven charges amounted to serious professional misconduct.
Paul Morris, chairing the Committee and speaking on its behalf said: “In considering the seriousness of the misconduct, the Committee took into account the fact that the misconduct had involved dishonesty, that there had been a risk of injury to animals and humans (though this risk had not materialised), and that the misconduct had occurred when the respondent, as an Official Veterinarian, occupied a position of increased trust and responsibility.”
He added: “The Committee considered that honest, accurate and careful veterinary certification was a fundamental component of the responsibilities of a veterinary surgeon.
"The matters which the Committee had found to be proved fell far short of the standards expected of a registered veterinary surgeon and amounted, in the Committee’s judgment, to disgraceful conduct in a professional respect.”
In considering the sanction for Dr Briggs the Committee heard positive character testimonials from former employers and clients, as well as a representative from the APHA who said that Dr Briggs had shown contrition for the breaches while recognising that there was unlikely to be a repetition of the conduct and that Dr Briggs was a relatively new and inexperienced vet at the time of her actions.
Mr Morris said: “In the Committee’s judgement the circumstances of the incident were a mitigating factor in the sense that the respondent was working in a pressurised environment, and in a field of practice which was unfamiliar to her.
"The Committee had heard a considerable amount of evidence from various witnesses that the surveillance system created, to monitor the prevalence of avian influenza was one which placed considerable pressure on OVs and, perhaps inevitably, had some shortcomings.
"The respondent had not worked with poultry before so her inexperience in this area fed into this situation.
“The Committee took into account the fact that no actual harm had occurred and there was no financial gain to the respondent.
"The matters with which the Committee was concerned formed a highly unusual, and short-lived, episode in the respondent’s career.”
The Committee also considered that Dr Briggs had made open and frank admissions regarding most of the charges against her and had also shown genuine contrition over her failings.
In light of this, the Committee considered that a reprimand and warning as to future conduct was the most appropriate sanction.
Mr Morris added: “False certification can never be acceptable.
"Veterinary surgeons should never certify any matter which they know, or ought to know, not to be true.
"However, the Committee considered that this case was at the lower end of the spectrum of gravity of false certification cases, that there is no future risk to animals and that the respondent has demonstrated insight.
"In relation to the public interest, the Committee considered that a reasonable and fully informed member of the public would recognise that, in all the circumstances of this particular case, a reprimand and warning as to future conduct would be sufficient to satisfy the public interest.”
www.rcvs.org.uk/disciplinary
Matthew’s award is in recognition of his paper Approach to initial management of canine generalised epileptic seizures in primary-care veterinary practices in the United Kingdom, co-authored with Laurent Garosi, which was selected by the BSAVA Committee as being the most valuable to veterinary practice.
James’ study explored data collected as part of the Small Animal Veterinary Surveillance Network (SAVSNET) at the University of Liverpool.
In total, clinical records concerning 3,150,713 consultations (917,373 dogs) were collected and analysed from 224 UK veterinary practices.
This included the management of canine generalised epileptic seizures in 517 dogs up to 6 years of age.
The study concluded that 98% of dogs presenting for a single epileptic seizure were not started on long-term therapy, in accordance with the approach recommended by the International Veterinary Epilepsy Task Force (IVETF).
Other findings from the study included:
The paper also reported on factors potentially associated with prescription of ASDs.
It stated that dogs who presented for cluster seizures (more than one epileptic seizure in a 24-hour period) were more likely to be prescribed ASDs, or to be referred to a specialist, than dogs without cluster seizures.
Dogs that were neutered or microchipped were more likely to be started on ASDs following the initial presentation, perhaps suggesting that owners who take part in regular preventative healthcare prior to the onset of their dog’s seizures could be more willing to start therapy in the earlier stages of the disease.
In addition, more than half of dogs with cluster seizures were not prescribed any ASDs.
Given that the presence of cluster seizures is typically considered an indication to start long-term therapy by the IVETF, Matthew says this may be one aspect of seizure management that could be improved in primary care practice.
Regarding the choice of anti-seizure drugs (ASDs), imepitoin was more frequently prescribed than phenobarbital in response to cluster seizures.
But unlike phenobarbital, the paper highlighted that the market authorisation for imepitoin does not include the treatment of cluster seizures.
Therefore vets should be aware that the use of imepitoin for cluster seizures should be considered as “off-licence” - and has additional implications for obtaining informed consent.
Matthew said: “We believe this research contributes to an improved understanding of the current management strategies for canine epilepsy in general practice and how this compares to the current guidelines advised by the IVETF.
"Given the prevalence of epileptic seizures within the UK canine population, as well as the large proportion of dogs that will be managed entirely within general practice without referral to a neurologist, it is vital to ensure that the level of care being provided is optimal.
"We therefore hope that this research ultimately supports and guides general practitioners in their approach to canine epilepsy, thereby improving the quality of life of affected dogs and their owners.”
https://onlinelibrary.wiley.com/doi/epdf/10.1111/jsap.13543
Virbac Animal Health has launched an extra small version of its VeggieDent dental chews for dogs weighing less than 5kg.
Research commissioned by the company shows that 9% of all dogs in the UK weigh less than 5kg1 and that periodontal disease is over-represented in this group2.
According to the Kennel Club, celebrity culture is boosting the popularity of small breeds. Apparently there was a 25% increase in Kennel Club registrations of Chihuahuas in 2011, following publicity about Paris Hilton and her Chihuahua. Virbac says numbers of other small miniature breeds such as pugs are also growing rapidly.
Virbac says VeggieDent chews are designed to work with the animal's chewing action, 100% vegetable, highly palatable and feature a special design to increase chewing time. A recent study3 showed that a daily XS VeggieDent reduced halitosis as well as significantly reducing gingivitis, plaque, and tartar accumulation.
Chris Geddes MRCVS, Product Manager at Virbac said: "With growing numbers of very small dogs in the UK, we wanted to produce a chew which was exactly the right size for them.
VeggieDent Chews are already popular among dog owners because they are a nutritious and palatable plaque control aid, minimising tartar build up and improving breath odour. With the launch of the extra small size, we now offer the perfect chew for every size of dog."
For further information, contact your Territory Manager or call Head Office on 01359 243243.
References:
Royal Canin has launched its second 'Weigh-in Club' competition to help cats and dogs lose weight safely.
Royal Canin says the competition is designed to reward veterinary nurses who work with their clients to tackle pet obesity effectively. Last year, it had over 170 registrations.
The competition is open to vet nurses whose clients' pets have undergone a supervised weight loss programme (being fed exclusively on Royal Canin diets) and have met their target weights. The overall winning nurse will receive £500 worth of high street shopping vouchers as well as £1,000 of equipment vouchers for their practice. Every nurse that submits a qualifying entry will receive a free silicone watch and two entries will win them a Royal Canin fleece.
Royal Canin's Gudi Stuttard said: "With canine and feline obesity on the increase, veterinary nurses have an important role to play in educating pet owners and supporting the weight loss process. That's why we're looking for the very best examples so that we can celebrate the success of nurses, practices and clients and demonstrate to other owners how important and achievable it is to help pets reach a healthy weight."
Participating practices will be sent competition materials for display, to encourage their weight-loss clients to take part in the competition. Nurses will also have the chance to track their entrants' progress on Royal Canin's new interactive website, where you can upload 'before and after' photos and compare weight loss with other competitors.
As an added incentive to pet owners, the overall winning client will receive free Royal Canin pet food for a year and £500 worth of high street shopping vouchers. The top 11 runners up will appear, alongside the winner, in an exclusive Royal Canin calendar and every owner that enters will receive a 'Company of Animals' Activity Pyramid to help them keep their pets in great shape.
Vet nurses can register online by visiting www.weighinclub.royalcanin.co.uk. This year's competition closing date is 30 September 2012, with the winner and runners up announced at the end of November.
The Kennel Club Charitable Trust has announced that nominations are now open for its new Veterinary Awards for veterinary surgeons, scientists and veterinary students that are carrying out innovative research that will help to improve dog health.
According to the charity, the Awards will identify and encourage visionary thinking, ambition and life-changing accomplishments and those who receive the awards will be passionate about making a difference for dogs. Each award provides a large funding programme to the recipient, which rewards them for their dedication and innovation in the field of canine health and welfare and invests in helping them to continue making a difference for dogs. The awards will be:
The awards will be judged by representatives from the veterinary profession and the world of scientific research, including experts in the nominees' selected fields. Dr. Alan Kelley, Dean Emeritus of The University of Pennsylvania School of Veterinary Medicine, will chair the distinguished committee selecting the International Prize Winner.
Vernon Hill, Founder and President of Metro Bank and Shirley Hill, whose Foundation underwrites the Awards, said: "Metro Bank is a visionary, innovative bank, and we support the same spirit in these prestigious awards. Dogs Rule at Metro Bank, and we welcome them in with fresh water bowls, treats and Metro Scarves 361 days a year. We look forward to our gift making a difference and supporting the future leaders in veterinary science."
Rosemary Smart, Kennel Club Chief Executive, said: "We are extremely pleased to be working with Vernon and Shirley in this exciting Awards scheme, which will reward and support those people whose work is making a difference to dogs' lives."
To nominate somebody for these awards contact: cas.oakes@thekennelclub.org.uk or write to:
Cas OakesThe Kennel Club Charitable Trust1-5 Clarges StreetPiccadillyLondonW1J 8AB
Nominations for the Student Inspiration should come from the Deans/Faculty Directors of British Veterinary Schools.
For further information and to find out how to enter visit: www.thekennelclub.org.uk/charitabletrust
The BSAVA reports that its inaugural Rehabilitation and Physiotherapy VN Merit Award is already fully subscribed, with places on other programmes proving hugely popular.
The association says it created the VN Merit Awards having identified a demand amongst nurses for focussed and cost-effective CPD which could fit into busy lives. Academic Director Dr Frances Barr said: "Veterinary nurses have an increasing desire to stretch their skills and expand their contribution to the clinical team, and the new awards will provide that opportunity. They deserve the support of the whole profession.
"VNs taking part in these programmes can expect to strengthen their theoretical knowledge and to learn important practical skills in an area of particular interest to them. At the end they will be taking greater confidence and new skills back into the practice which they can share with the wider practice team."
Despite being a brand new course, BSAVA says that there there is clearly faith that it can continue to deliver relevant, challenging CPD for nurses. The first two Merit Awards will run in autumn 2012. All the places on Rehabilitation and Physiotherapy have been booked, but interested individuals can join a waiting list for the next course. Anaesthesia and analgesia has also proved popular, with just a few places left, at the time of writing. Further merit awards in wildlife nursing and in surgical nursing are planned for 2013.
For further information, email courses@bsava.com or visit www.bsava.com/cpd.
The BVA has welcomed an update report on dog breeding issues by the Associate Parliamentary Group for Animal Welfare (APGAW).
Working with a small group of stakeholders including the British Veterinary Association, Dogs Trust, Kennel Club and RSPCA, this report looks at what has been done since the first APGAW report in late 2009 and the airing of Pedigree Dogs Exposed (2008) and Pedigree Dogs Exposed: Three Years On (2012).
BVA Past President Harvey Locke said: "The BVA fully endorses the recommendations and practical solutions offered by this timely report."
Mr Locke drew attention to a number of points in the report's action plan including:
Mr Locke added: "I am pleased that the APGAW report recognises the vital role that education plays in tackling irresponsible dog ownership and would very much like to see the inclusion of animal welfare as part of the core curriculum.
"I am also delighted that the group recognises the value of a puppy contract. The BVA Animal Welfare Foundation and RSPCA have recently launched a puppy contract and puppy information pack (PIP) which arms buyers with the knowledge to give themselves the best chance of getting a fit, healthy and happy, well socialised pet to join their household. The contract and PIP have also been designed to help good breeders demonstrate the care and attention they have devoted to their puppies' breeding and upbringing.
"Much work has already been undertaken to improve dog breeding but there is much more to be done and the momentum must not be lost. I am most grateful to Neil Parish MP, chairman of APGAW, for his commitment to producing this report. It is an excellent means of keeping the issue high on the agenda by encouraging wider dialogue and debate within Parliament and in the EU."
The anti-emetic, Cerenia (maropitant citrate), has gained licenses for use in puppies from as young as eight weeks of age and in cats from 16 weeks of age in the prevention and treatment of vomiting and reduction of nausea.
Cerenia is an NK-1 receptor antagonist which Pfizer says is effective against both peripheral and central emetic stimuli by acting on the final common pathway for emesis. It is, according to the company, the only NK-1 receptor antagonist licensed for dogs and cats.
Pfizer adds that in addition to the use for general emesis in puppies, Cerenia can also be used for chemotherapy-induced nausea in dogs. Studies in human oncology show that some patients receiving chemotherapy consider nausea to be more distressing than vomiting1. and the use of NK-1 receptor antagonists has shown clear benefits in the prevention of nausea and vomiting in chemotherapy-treated humans2. Cerenia tablets are also for the treatment for motion sickness in dogs aged 16 weeks or older, delivering claimed efficacy up to 93% without sedating the dog.
Kate Grocott, Product Manager for Cerenia, said: "Already successfully used in the treatment and prevention of vomiting and chemotherapy nausea in dogs, the new licence is a positive step forward for the prevention and early treatment of vomiting for puppies as young as eight weeks of age and cats from 16 weeks old. Being able to deploy Cerenia in these cases, will improve quality of life, and increases the likelihood of the animal voluntarily taking food and water thereby assisting in the recovery where there is underlying disease."
The new licence for treatment of cats with Cerenia is associated with the injectable form, while puppies may be treated with either an injection or tablets.
For further information, contact your Pfizer Animal Health account manager or call 0845 300 8034.
References
At the meeting, which took place last Thursday, Council members were asked to decide how to proceed with three specific proposals on reforming the disciplinary system:
Acknowledging some of the concerns that have been raised about changing the standard of proof, RCVS Registrar Eleanor Ferguson said: “The RCVS is now one of just a few regulators that still uses the criminal standard of proof in determining the facts of a case. We have sought these changes as part of our ongoing aim to develop a compassionate and forward-looking disciplinary system with the protection of the public absolutely at its heart, whilst also acknowledging the huge toll the process takes on the mental health of veterinary professionals.
"Research that we carried out into the impact of changing the standard of proof indicated that it would not lead to a major increase in cases being referred from the Preliminary Investigation Committee to the Disciplinary Committee. Importantly the number is likely to be very low because the standard of proof only applies to proving the facts of a case; the judgement as to whether proven facts amount to serious professional misconduct will follow the same process as at present.
"We estimated that during 2019, there could have been just two more cases brought to DC under a altered standard of proof, with an additional three cases that were borderline but probably wouldn’t have proceeded any further. Conversely, we also estimated that three cases that did go to DC during 2019 would probably not have done, had the ‘Charter Case Committee’ option been available.
"Ultimately, the aim of the RCVS in regulating the veterinary professions is to protect the public and animal welfare as well as upholding the reputation of the professions. We believe these changes will better achieve that aim."
The consultation on whether to change the standard of proof as well as to introduce the Charter Case Protocol and ‘mini-PICs’ is now planned for later this year.
Further information about the proposals, including some of the arguments for and against changing the standard of proof, can be found in the papers for RCVS Council at: www.rcvs.org.uk/who-we-are/rcvs-council/council-meetings/4-june-2020/ (pages 70-97).
Virbac Animal Health has launched Speed Leish K, a diagnostic test for canine leishmaniosis.
Speed Leish K detects antibodies directed against the kinesins of leishmania using a Kinesin Capture Complex (KCC), a complex of recombinant proteins with strong immunogenic power at all stages of infection. Virbac says that in trials the test has demonstrated 98.5% overall accuracy.*
Virbac Product Manager Simon Boulton MRCVS said: "Leishmaniosis presents a growing threat to UK dogs, particularly those which travel with their owners on holiday to regions where the disease is endemic.
"Speed Leish K should be used as part of the primary CaniLeish vaccination protocol in animals previously at risk of exposure to ensure only health animals are vaccinated. The test can also be used to screen for the disease in animals suspected to be infected."
Speed Leish K is presented in kits of two or six tests and can be stored for 24 months at room temperature.
The Badger Trust's legal challenge to Defra's plans for targeted badger cull pilots has failed in the High Court on all three grounds.
Whilst the RSPCA has expressed its disappointment, the British Veterinary Association and British Cattle Veterinary Association have welcomed the judgement.
BVA President Carl Padgett said: "We are pleased that the High Court has ruled Defra's policy lawful and that the pilot badger culls can now go ahead.
"The BVA and BCVA believe that the government's approach has been robust and justifiable as it is based on our current scientific knowledge.
"Bovine TB is a devastating disease and we must tackle the disease in wildlife alongside cattle controls if we are to get on top of it."
David Bowles, the RSPCA's Director of Communications, said: "We are bitterly disappointed that the UK Government in England is ploughing on with plans to kill badgers but the fight is not over yet.
"We believe culling is not a long-term, sustainable solution and will be of little help in reducing the disease - perhaps even making things worse in some areas. It will wipe out huge numbers of this much-loved species, virtually eliminating badgers from these areas, including many animals which are healthy.
"It is not as if there aren't alternatives to a cull. Vaccination could be a more effective and sustainable way of dealing with the disease, and one which does not involve killing most of the badger population in very large areas of the countryside."
Petplan has launched a new service to pay vet claims direct to practice bank accounts via BACS.
Petplan says it pays out nearly £3 million in claims each week, which is the equivalent of paying £35,000 per year to each veterinary practice in the UK. Paying practices by BACS means that the money is received faster and there is no administration required by the practice, freeing up more time for clinical work.
As part of this new service, practices also receive a detailed statement by email providing a breakdown of the client claims the payment relates to.
To register to receive claim payments by BACS, visit petplanvet.co.uk and complete an online form.
Simon Masding, Petplan's Head of Sales and Partnerships said: "Petplan has a great relationship with vet surgeries and we know in the last few years some practices have had increasing pressure on cash flow due to reduced footfall and rising costs. We are constantly looking for new, smarter ways of working to help our partners and wanted to get claim payments to vets even faster."
Petplan's Vet of the Year Brian Faulkner said: "Most people become vets because they love to work with animals, and the paperwork is merely a downside of the job. It's great to see that Petplan has reduced the time we have to dedicate to admin, meaning we can concentrate on the important things, like improving the health of Britain's pets."
For more information visit www.petplanvet.co.uk
Dechra Veterinary Products has published a range of case studies to support its new campaign focused on the diagnosis and treatment of otitis externa.
The studies have been written by Referral Dermatologist Sue Paterson MA, VetMB, DVD, DipECVD, MRCVS, RCVS European Specialist in Veterinary Dermatology and Peter Forsythe BVM&S, DVD, MRCVS, RVCS Specialist in Veterinary Dermatology.
Developed as part of the Time to Change campaign, the real-life examples feature a series of problems and solutions associated with otitis, supported by clear images and photomicrographs.
Larry King, Senior Brand Manager, Dechra Veterinary Products, said: "We have created a range of in-depth case study materials for use by vets and vet nurses which will support identification and management of otitis externa, one of the more frequent conditions seen in general practice.
"As veterinary professionals are aware, otitis is common and can be challenging to diagnose and treat. These studies address individual cases and demonstrate how the Dechra dermatology range can be used effectively.
"Topics covered in the case studies include the types of otitis presented by each animal, how individual organisms were identified using cytology and how long treatment was continued."
The case studies, which feature Malassezia, staphylococcal and Proteus infections, also discuss the underlying causes and steps taken after treatment with Canaural and various ear cleaners.
The Time to Change campaign has been launched to support a best practice approach to otitis which includes the identification of the organisms causing infection through cytology, support the selection of the correct treatment and assist with educating clients on how to apply and use products correctly.
For further information visit www.dechra.com/timetochange. The website also highlights the benefits of Dechra Veterinary Products' range of topical treatments and ear flushes, including Canaural, CleanAural, CerumAurual, TrizAural and MalAceticAural.
Virbac Animal Health is calling on practices to prepare for Canine Prostate Awareness Month (CPAM), being held by the company in November to highlight the prevalence of the disease and to encourage owners and practices to test for it.
Last year, 400 practices sign up to support the event, and the company says that feedback from many taking part confirmed a significant lack of understanding among clients as to the risk of prostate disease in dogs.
Canine Prostate Awareness Month is timed to coincide with 'Movember', when thousands of men grow moustaches to raise funds for male prostate and testicular cancer. During the month, Virbac is providing promotional materials including dog leads; educational and display materials and a press release for local media.
Chris Geddes MRCVS, Virbac Product Manager, said: "With more than 80% of entire male dogs over the age of five suffering from Benign Prostatic Hyperplasia (BPH)¹, we wanted to give practices a reason to highlight the risk and encourage owners to test for it. Timing CPAM to coincide with Movember seemed a good way to interest dog owners at a time when some might be considering the state of their own prostate.
"The support we received last year confirmed that it was a topic which practices were keen to discuss with dog owners so we're already planning to make the initiative even bigger and better this year."
Stephen Bamber, Principal at participating practice Warwickshire-based Avonvale Vets, added: "CPAM was an attractive campaign as it was a bit different. It offered the opportunity to see some of our older patients with other, less obvious pathologies. Non-symptomatic testicular tumours in particular surfaced in the checks we did. Clients generally had little idea about dogs' prostates so it gave us a good platform to discuss prostate disease with them."
Virbac has introduced OdelisTM CPSE, the first ELISA test to screen for, diagnose and monitor BPH, available from three UK diagnostic laboratories. The company says it's a cost-effective, precise and reliable alternative to rectal palpation. Virbac also offers Ypozane, a tablet treatment for BPH which takes effect within a week and lasts for up to six months.
Chris added: "BPH is an unpleasant condition occurring in nearly all entire dogs as they get older, but one which is entirely treatable. We hope that, by running our Prostate Awareness Campaign at a time when the media spotlight is already on the dangers of prostate cancer in men, we can help spread the message that owners should be monitoring older dogs for signs of prostate disease."
For further information on the Prostate Awareness Campaign, email cpam@virbac.co.uk; contact your Virbac Territory Manager or contact the company direct on 01359 243243.
The Webinar Vet has released the results of a survey which shows that its members are far exceeding their 35 hour CPD target.
Launched just over two years ago, The Webinar Vet was the first company in the UK to specialise in web-based CPD for vets and now has nearly 1000 members from around the globe.
The Webinar Vet founder Anthony Chadwick MRCVS said: "Our members average over 60 hours of online CPD per year. Indeed several members are exceeding 100 hours a year including workshops, and some have even recorded over 200 hours of total CPD!
"There will always be a need for workshop CPD, but most vets and VNs can get the majority of the updates and information they need online. However we believe that in many cases it's not a simple swap - the convenience of online CPD means that many vets and VNs are earning more total hours, which can only be a good thing for the profession.
"Many vets and VNs are juggling busy family lives with work in practice, and the convenience of viewing and participating in webinars from your own home or in a practice lunch break is both cost and time saving, not to mention the reduction in carbon footprint."
Boehringer Ingelheim Vetmedica has launched a new Canikur Pro website - www.canikurpro.co.uk - to provide pet owners with advice on digestive upset and offer a quick reference guide to using Canikur Pro.
The site offers information about the common causes of digestive upset, including dietary indiscretions, stress due to a change in circumstances and underlying gut problems.
The site also contains information about how Canikur Pro works, how to give the product and where to buy it, plus tips for supporting the recovery of a dog's gut health such as providing a constant supply of fresh water, offering a bland diet and providing access to outside areas to reduce accidents.
In addition, the site contains a 'veterinary only' area where veterinary professionals can download client materials.
The mandatory regulation of veterinary practices, including statutory powers of entry and inspection, is one of the main parts of the College's proposals for new primary legislation that would replace the current Veterinary Surgeons Act 1966.
The working group, which is expected to present the details of a Mandatory Practice Regulation system to Council by the end of 2024, will be chaired by RCVS President Sue Paterson FRCVS.
It will include Standards Committee Chair Linda Belton MRCVS and Practice Standards Group Chair Belinda Andrews-Jones RVN, alongside veterinary, veterinary nursing, lay and external representatives.
Sue said: “With over 70% of practice premises currently under its ambit, our Practice Standards Scheme (PSS) has shown how keen practices are to maintain high standards.
"However, it is a voluntary scheme and, as a result, there is no mechanism to ensure standards across all practices, or to ensure change in those rare situations where it is needed.
“At present, the RCVS only regulates individual veterinary surgeons and nurses, and the veterinary sector does not have an equivalent to the Care Quality Commission, which considers human healthcare premises.
"This means that the onus for maintaining standards within the workplace falls on regulated individuals rather than the business structure.
"We will consider what a scheme that puts more statutory responsibility on business owners to maintain standards should look like.
“I look forward to working with colleagues in RCVS Council, VN Council and other veterinary organisations via this group to really flesh out what this regulatory system might look like in the future, to make sure it is appropriate, robust, proportionate and enforceable.
"Establishing these details will also prove invaluable in our lobbying work with government, ministers and MPs.”
Dr Vlad Butnaru faced two charges, the first of which was that in May 2021, he had signed a passport and/or passport application for a horse and electronically signed a declaration stating that he “had read the above microchip, which had previously been implanted for the animal” when, in fact, the microchip had not been inserted into any horse and he had not read it.
The second charge was that, in relation to the matters set out in the first charge, Dr Butnaru’s signed declaration was false, and that he had acted dishonestly and misleadingly, he risked undermining procedures designed to promote animal welfare, and failed to take sufficient steps to ensure that the microchip number recorded for the horse was accurate.
Dr Butnaru admitted the first charge on all counts, and that the declaration he had signed was false.
He also admitted that his conduct was misleading and that he had failed to take sufficient steps to ensure that the microchip number recorded for the horse was accurate.
However, he denied that his conduct had been dishonest and that he had risked undermining a procedure designed to promote animal welfare.
In its decision, the committee noted that Dr Butnaru kept introducing new versions of what happened for the first time at the hearing and changed his account as he went along, as well as being evasive when answering questions.
The Committee therefore felt that Dr Butnaru could not be considered to be a reliable witness, and whilst it did not know the true reason why he was prepared to sign a false declaration on a passport application, it was satisfied that he'd made a false declaration dishonestly.
The Committee also found that Dr Butnaru had failed to take sufficient steps to ensure that the microchip number recorded for the horse was accurate as, if the passport had been issued on a false premise because of misleading information provided by Dr Butnaru, then it could not function as it was meant to which, in the Committee’s view, clearly risked undermining procedures designed to protect animal welfare.
The Committee found that Dr Butnaru had breached the parts 6.2 and 6.5 of the Code of Professional Conduct, as well as Principle 1 of the 10 Principles of Certification, namely that ‘a veterinarian should certify only those matters which: a) are within his or her own knowledge; b) can be ascertained by him or her personally; c) are the subject of supporting evidence from an authorised veterinarian who has personal knowledge of the matters in question; or d) are the subject of checks carried out by an Officially Authorised Person (OAP).’
The Committee found there were no mitigating factors.
Aggravating factors, on the other hand, were that Dr Butnaru had participated in premeditated misconduct, made financial gain from his actions as he was paid to make the false declaration, abused his professional position, and showed blatant or wilful disregard of the Horse Passport System and of the role of the RCVS and the systems that regulate the veterinary profession.
The Committee found that all proven charges amounted to Disgraceful Conduct in a Professional Respect.
On considering the sanction, the Committee once again considered the aggravating factors, as well as additional mitigating factors in that Dr Butnaru had no previous disciplinary history, showed limited insight by admitting to some of the charges, showed expressions of remorse, and was provided with a positive testimonial.
Paul Morris, chairing the Committee and speaking on its behalf, said: “The Committee was cognisant of the importance of a veterinary surgeon’s signature on any document.
"This should have been obvious to any veterinary surgeon, but particularly someone of Dr Butnaru’s 11 years’ experience (at the time of signing).
"The Committee was well aware of the impact and ramifications for Dr Butnaru of any decision to remove him from the Register, but had to weigh his interests with those of the public.
“In doing so it took account of the context and circumstances of the case, all matters of personal mitigation, Dr Butnaru’s previous unblemished record and the need to act proportionately.
"However, the Committee was of the view that the need to uphold proper standards of conduct within the veterinary profession, together with the public interest in maintaining confidence in the profession of veterinary surgeons and protecting the welfare of animals, meant that a period of suspension would not be sufficient.
"His actions were fundamentally incompatible with remaining on the Register and thus the only appropriate and proportionate sanction in all the circumstances of this case was that of removal from the Register.”
https://www.rcvs.org.uk/concerns/disciplinary-hearings
Norbrook Laboratories Ltd has announced the launch of Pestigon, a fipronil spot-on solution for cats and dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Pestigon offers a fast-acting and long-lasting treatment for cats and dogs suffering from flea and tick irritations. The new product will have an immediate effect against flea infestations and will kill ticks within the first 24 - 48 hours of application. Fipronil is a tried and tested ingredient with proven efficacy against fleas and ticks. Pestigon provides a fast-acting treatment whose effectiveness will continue against new infestations of fleas for up to 58 days on dogs and 37 days in cats and against ticks for up to 30 days in dogs and 21 days in cats."
To coincide with the launch of Pestigon, Norbrook has rebranded its Permaguard household spray which is now available with 12 month protection.
Rebekah said: "The total life cycle of a flea can last from a couple of weeks to several months. Only adult fleas live on cats or dogs while the eggs, larvae and pupae can be found around the house in carpet, furniture, bedding etc for up to a year or more. It is therefore crucial that pet owners treat the household to break the life cycle and ensure effective and lasting flea control. Pestigon and Permaguard together will give pet owners a complete treatment."
Pestigon range offers 5 alternatives for cats and dogs depending on size and comes with colour co-ordinated pipettes available in packs of 3, 6 and 24 to allow for single or multiple pipette dispensing.
Norbrook's Small Animal Brand Manager, Michelle Jones said: "Pestigon is licensed as a POM-V product and will be sold exclusively through veterinary practices. We have produced a range of marketing materials for veterinary practices to help them offer support on flea and tick control in the home to their customers."
Orders for Pestigon and Permaguard can be placed through your Norbrook representative now.
The Kennel Club is hosting its second Puppy Awareness Week to help improve the health and lives of dogs around the UK, and is seeking assistance from the veterinary profession.
Puppy Awareness Week is taking place from 8th - 14th September and aims to help people find a healthy, happy puppy that is right for their lifestyle, whilst raising awareness about the plight of puppies and breeding bitches born into cruel puppy farms.
To help, veterinary surgeons and nurses are being asked to join in the week, putting up posters and literature in client waiting areas, and selling Puppy Awareness Week badges for £2, which will go to the Kennel Club Charitable Trust.
Caroline Kisko, Kennel Club Secretary said: "It is vitally important that we spread the word about buying puppies responsibly. At veterinary surgeries there is a captive audience of animal lovers and we can't think of anyone better to communicate with. Not only are a vet's clients animal lovers and as such, potential new dog owners, but they may also make great champions of the cause, spreading the message about buying a puppy responsibly further afield.
"Sadly, we are seeing tens of thousands of puppies born each year suffer as puppy farms churn out litter after litter of undernourished and badly cared for puppies, and then selling them on to unsuspecting owners through pet shops, newspaper ads, online adverts and various other means. With help from veterinary practices we want to provide information throughout Puppy Awareness Week to help people understand how to buy a healthy, happy puppy, and to raise money for the Kennel Club Charitable Trust, which supports charities and organisations that are making dogs' lives better."
To get involved in Puppy Awareness Week and receive literature and Puppy Awareness badges, contact the Kennel Club press office at press.office@thekennelclub.org.uk.
Puppy Awareness Week will kick off at Pup Aid on September 8th in Primrose Hill, London and will run until 14th September. To find out more, visit www.thekennelclub.org.uk/paw.
Organisers of the Vet Charity Challenge are calling for more people to take part in the event, to join the 100 that are already set to walk, run, cycle, kayak and orienteer around the grounds of the Royal Agricultural College in Cirencester on On 15th September.
Gavin Mitchell from BCF Technology said: "We have entered two teams and already have a £100 bet on which of our teams will gain the most points on the day. This rivalry has certainly had a positive influence on the amount of training we are all doing to prepare for the challenge. The teams are out cycling after work and off for runs during lunchtimes."
Gavin added: "We are keen to ensure we beat the other teams such as those from Vets Now, and Clent Hills Vet Group. No pressure!"
Teams are also starting to gather sponsorship for the three chosen charities of SPANA, Hounds for Heroes and Pet Blood Bank. The team that raises the most amount will win a day's in-practice imaging training with the BCF in-house vet Kimberly Palgrave, BS BVM&S GPCert(DI) MRCVS.
Andrew Groom from Kruuse said: "This is a great focus to help get fit over the summer months, build team spirit within a practice and enhance a practice's profile locally, as well as raising money for some great causes. There is still room for a few more teams, so we urge practices to not wait any longer and sign a team up now."
For more information visit www.vetcharitychallenge.co.uk, call 01727 859 259 or find it at www.facebook.com/vetcharitychallenge
Ceva Animal Health has produced a leaflet to help horse owners understand the cause, diagnosis and management of equine back pain.
The company says the management of back pain in the horse can be a particular challenge to vets and a source of frustration for owners. Early diagnosis is likely to be associated with a more favourable outcome but it's important to ensure that other causes of pain and poor performance such as lameness, are not contributing to the horse's clinical signs.
'Understanding back pain' explains the anatomy of the back, as well as the clinical signs of back pain, and how it is diagnosed, including the treatment options and the general prognosis. Copies of the new leaflet are available, free of charge, from your Ceva sales representative. Leaflets on 'Understanding bone spavin', 'Understanding navicular disease', 'Understanding sacroiliac disease' and 'Equidronate discharge instructions', are also available.
For further information contact your local Ceva representative or Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
The group says it has led to 6,086 more clinical metrology questionnaires being conducted at participating practices with their patients, a 1,014% increase.
Developed by John Innes at the University of Liverpool, the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire is a 13-item clinical metrology instrument (CMI) used to assess canine articular disorders like osteoarthritis.
It includes questions on the pets’ medical background, lifestyle and mobility.
Individual question scores are summed to provide an overall “LOAD score” suggestive of the animal’s disease presence and severity.
The questionnaire should be conducted every time the pet is presented to the veterinary clinic, with results tracked over time.
Treatment options - including the benefits and risks of all available modalities – can then be considered and discussed with owners to determine the best course of action, including weight management, diet, supplements, exercise and environmental modification, in addition to medication.
As part of the project, CVS provided a range of supporting resources for its practices, together with training.
Training focussed on diagnosing and managing conditions causing lameness in dogs and cats, using the clinical metrology questionnaire to engage clients in their pets’ treatment plan, offering best practice treatment options and running nurse mobility clinics.
It comprised of a vet CPD day run with Zoetis and the VOA on approach to and management of lame patients, two nurse CPD days on mobility clinics, a feline and canine orthopaedic examination video, First Opinion Clinical Club webinars on canine and feline osteoarthritis and an approach to radiographic interpretation course.
Resources included: new clinical guidelines, IMV resources (radiographic positioning, optimising the image and optimal chemical restraint) and a Mobility Clinic Booklet for clients.
Each site was then provided with its own data, so that they could monitor what they were doing individually.
One year after its nation-wide launch, results reveal that the number of clinical metrology questionnaires being conducted in the 35 participating practices has increased from 6 to 6,092 over a 12 month time period.
CVS says there was also evidence of an increasing incidence of the osteoarthritis drugs Librela and Solensia being prescribed.
Kathryn Patel, Hub Clinical Lead at CVS (pictured), who was responsible for the lameness clinical improvement project, said: “This project uses owner questionnaires to screen for and monitor the impact of lameness on patient quality of life and emphasises the importance of the whole clinical team in patient management.
"Vets and nurses will be supported to improve their ability to reach a diagnosis in every lame case, improve engagement with and compliance of owners with lame pets, and improve the quality of care of lame patients through appropriate medication, surgical intervention, and nurse and physiotherapy support.”
Pfizer Animal Health's Equine Herpes Virus (EHV) vaccine (Duvaxyn EHV 1,4) has been rebranded Equip EHV 1,4).
Pfizer says that EHV is carried by most horses in the UK1 and can cause respiratory disease, abortion and more rarely neurological disease. However, it is the more common sub-clinical infections that pose the most apparent issue for the competition client, with the associated loss of performance and the potential effect on the health of the whole yard.
Once infected with EHV, a horse can harbour the virus throughout its life and potentially shed the disease to other animals without showing any outward signs. According to the company, vaccinating helps to minimise the severity of the disease itself and importantly, can also help to reduce the amount of infective virus that is shed to other in-contact horses.
Equip EHV 1,4 is given as a primary course of two vaccinations, 4-6 weeks apart followed by a single dose every six months. It can also be used as an aid in the control of EHV-1 abortion - pregnant mares should be vaccinated with a single dose during each of the 5th, 7th and 9th months of pregnancy.
For further information on Pfizer's EHV campaign, to obtain literature for your practice or to book a talk for your clients contact your Pfizer Account Manager or Pfizer Animal Health, Walton Oaks, Tadworth, Surrey KT20 7NS.
Reference
1. Eddington et al. Equine Vet. J. 1994; 26 (2): 140-142.